Petra Hegmann, Author at MC Services corporate website

-1

archive,author,author-petra-hegmann,author-9,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.1,vc_responsive

Heidelberg Pharma reports on first half-year 2020

VAXIMM Appoints Thomas D. Szucs, MD, as Chairman of the Board

APEIRON Biologics and MaxCyte Enter into Clinical and Commercial Licensing Agreement for APN401

HepaRegeniX GmbH achieves successful proof of efficacy in acute liver disease models for selected MKK4 inhibitors

Rentschler Biopharma SE: The key to tackling drug development complexity: Collaboration. Rentschler Biopharma and Vetter team up with joint goal to simplify

Heidelberg Pharma reports on first half-year 2020

VAXIMM Appoints Thomas D. Szucs, MD, as Chairman of the Board

APEIRON Biologics and MaxCyte Enter into Clinical and Commercial Licensing Agreement for APN401

HepaRegeniX GmbH achieves successful proof of efficacy in acute liver disease models for selected MKK4 inhibitors

Rentschler Biopharma SE: The key to tackling drug development complexity: Collaboration. Rentschler Biopharma and Vetter team up with joint goal to simplify

Abivax treats first patient in Phase 2b/3 ABX464 Covid-19 clinical trial

PAION announces U.S. FDA Approval of remimazolam (BYFAVOTM) for the induction and maintenance of procedural sedation

Publication in PNAS unveils molecular pathway required for influenza virus replication with large potential as an antiviral drug target

MagForce AG Publishes Financial Results for the Year 2019 and Operative Highlights

CENTOGENE AG: CENTOGENE, Lufthansa, and Fraport Launch the First Walk-In COVID-19 Testing Facility in Germany at Frankfurt Airport